Split History
ETFs Holding BIOC »    BIOC Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biocept is a molecular oncology diagnostics company that develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid. Co. has commercialized its CNSide and Target Selector assays for detecting and characterizing various different carcinomas derived from epithelial cells of solid organs such as: breast cancer, non-small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. In addition, Co. has launched RT-PCR Coronavirus testing at its laboratory. According to our BIOC split history records, Biocept has had 3 splits.
BIOC split history picture
Biocept (BIOC) has 3 splits in our BIOC split history database. The first split for BIOC took place on September 29, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of BIOC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split. BIOC's second split took place on July 10, 2018. This was a 1 for 30 reverse split, meaning for each 30 shares of BIOC owned pre-split, the shareholder now owned 1 share. For example, a 333.333333333333 share position pre-split, became a 11.1111111111111 share position following the split. BIOC's third split took place on September 08, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of BIOC owned pre-split, the shareholder now owned 1 share. For example, a 11.1111111111111 share position pre-split, became a 1.11111111111111 share position following the split.

When a company such as Biocept conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the BIOC split history from start to finish, an original position size of 1000 shares would have turned into 1.11111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biocept shares, starting with a $10,000 purchase of BIOC, presented on a split-history-adjusted basis factoring in the complete BIOC split history. BIOC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/05/2014
End date: 01/30/2023
Start price/share: $8,460.00
End price/share: $0.55
Dividends collected/share: $0.00
Total return: -99.99%
Average Annual Total Return: -65.79%
Starting investment: $10,000.00
Ending investment: $0.65
Years: 8.99
Date Ratio
09/29/20161 for 3
07/10/20181 for 30
09/08/20201 for 10
BIOC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BIOD Split History
BIOL Split History
BLCM Split History
BLPH Split History
BLRX Split History
BLUE Split History
BMRA Split History
BMY Split History
BNTC Split History
BOLT Split History

Also explore: BIOC shares outstanding history

Email EnvelopeFree BIOC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BIOC Insider Buying

BIOC Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.